You are here: Industry Insights > ALS

News List

Mitsubishi Tanabe Pharma America Announces Collaborative Study To Identify And Measure Biomarkers In People With ALS americanpharmaceuticalreview
December 10, 2018
Mitsubishi Tanabe Pharma America, Inc. will conduct a study to identify and measure specific biomarkers in people with amyotrophic lateral sclerosis (ALS).....
ALS Organizations Collaborate to Advance New Therapeutic into Trials pharmafocusasia
December 03, 2018
Several ALS organizations announced on Wednesday that the first participant was successfully given a dose of AT-1501 in the first in-human trial of the potential treatment for ALS.
Sangamo and Pfizer announce collaboration biospectrumasia
November 19, 2018
Currently, there are no cures to halt or reverse the progression of ALS or FTLD. The C9ORF72 mutation is linked to approximately one-third of cases of familial ALS
Organs-on-chip technology reveals new drug candidates for Lou Gehrig's disease worldpharmanews
October 12, 2018
The investigation of amyotrophic lateral sclerosis (ALS) - also known as Lou Gehrig's disease - through muscle-on-a-chip technology has revealed a new drug combination that may serve as an effective treatment of the progressive neurodegenerative disease.
PARP inhibitors show promise for treating ALS and other brain disorders fiercebiotech
August 10, 2018
AstraZeneca’s Lynparza and Tesaro’s Zejula—part of an emerging class of cancer medicines known as PARP inhibitors—are on the market and being used to treat ovarian cancer with BRCA mutations.
Muscle discovery could open new treatment paths for ALS and other neuron disorders fiercebiotech
July 30, 2018
Cells that promote muscle repair have a dark side—a tendency to change so radically that they actually cause wasting and scarring rather than healing....
Aquinnah Pharmaceuticals receives $3.4 million grant to advance ALS therapies pharmafile
June 22, 2018
Aquinnah Pharmaceuticals has announced that it has been awarded a $3.4 million grant from the National Institute of Neurological Disorders and Stroke (NINDS) to advance novel therapeutic drug candidates
Neuraltus Pharmaceuticals Reports Results from Phase 2 NP001 Study in Amyotrophic Lateral Sclerosis (ALS) biospace
April 27, 2018
Neuraltus Pharmaceuticals, Inc today announced findings from a confirmatory Phase 2 study of its investigational therapy, NP001, in ALS patients with elevated levels of systemic inflammation.
Legend Dies! Hawking’s Gone, but ALS Drug Development Should Continue Yuntian
March 27, 2018
The legendary life of Hawking ended on March 14, 2018 by when Hawking fought against the well-known amyotrophic lateral sclerosis (ALS) for 55 years.
New ALS gene discovered: KIF5A biospectrumasia
March 26, 2018
ALS Ice Bucket Challenge donations funded research toward this important discovery

Previous page 1 2 3 4 5 6 7 8 Next page